caption
stringlengths 6
2.51k
| molecule
stringlengths 1
747
| properties
sequencelengths 1
86
|
|---|---|---|
The molecule is a cb1 antagonist that belongs to both the asthma treatment and cannabinoid receptor modulator classes of molecules, and it impacts obesity treatment. | CC(NC(=O)C1(C)COc2ccccc2C1)C(Cc1ccc(Cl)cc1)c1ccccc1 | [
"asthma treatment",
"cb1 antagonist",
"obesity treatment",
"cannabinoid receptor modulator"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome and tangier disease. The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, aging, and diabetic heart disease. | CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Cholesterol translocation",
"Barth syndrome",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Aging",
"Diabetic heart disease"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts barth syndrome, tangier disease, and aging. | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCC | [
"Apoptosis",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Aging",
"Cholesterol translocation"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts aging. The molecule is a cholesterol translocation that impacts non-alcoholic fatty liver disease, diabetic heart disease, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Aging",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Barth syndrome",
"Tangier disease"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts diabetic heart disease and tangier disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts barth syndrome, aging, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Diabetic heart disease",
"Tangier disease",
"Apoptosis",
"Barth syndrome",
"Aging",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease"
] |
The molecule is a inflammatory and energy source, affecting cancer, and impacting cardiovascular disease, obesity, and pancreatitis. The molecule is a membrane stabilizer and a energy storage, belonging to the thyroxine treatment class of molecules. The molecule is a fat storage and a nutrient, impacting both metabolic syndrome and atherosclerosis. | CCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)CC | [
"Cardiovascular disease",
"inflammatory",
"Obesity",
"Cancer",
"Energy source",
"Pancreatitis",
"Membrane stabilizer",
"Energy storage",
"Thyroxine treatment",
"Metabolic syndrome",
"Fat storage",
"nutrient",
"Atherosclerosis"
] |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation that impacts diabetic heart disease and tangier disease. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Aging",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Cholesterol translocation",
"Tangier disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a renin inhibitor. | COCCCOc1cc(N(C(=O)C2CN(C(=O)OC(C)(C)C)CCC2c2cccc(-c3ccccc3)c2)C2CC2)ccc1C#N | [
"renin inhibitor"
] |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts diabetic heart disease, tangier disease, and barth syndrome. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts aging and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Diabetic heart disease",
"Tangier disease",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Aging",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation"
] |
It impacts cancer treatment. | Cl.O=C(O)c1cc(F)cc2c1OCOC2 | [
"cancer treatment"
] |
The molecule is a stabilizing mitochondrial structure and a emulsifier, impacting both tangier disease and diabetic heart disease. The molecule is a membrane stabilizer, apoptosis, cholesterol translocation, energy source, energy storage. The molecule is a surfactant and a stabilizing cytochrome oxidase, it impacts non-alcoholic fatty liver disease, and is smooth. The molecule is a food additive, proton trap for oxidative phosphorylation, nutritional supplement that impacts aging and barth syndrome. | CCC(C)CCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Tangier disease",
"Diabetic heart disease",
"Emulsifier",
"Membrane stabilizer",
"Apoptosis",
"Cholesterol translocation",
"Energy source",
"Energy storage",
"surfactant",
"Stabilizing cytochrome oxidase",
"Smooth",
"Non-alcoholic fatty liver disease",
"food additive",
"Proton trap for oxidative phosphorylation",
"Aging",
"Nutritional supplement",
"Barth syndrome"
] |
The molecule is a cholesterol translocation that impacts aging, tangier disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Apoptosis"
] |
The molecule is a nutrient. | CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CC(O)CCC)COP(=O)(O)OC[C@H](N)C(=O)O | [
"nutrient"
] |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, aging, and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C | [
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Diabetic heart disease",
"Aging",
"Tangier disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation"
] |
It belongs to the anti viral class of molecules. | CC12CC3CC(C(=O)NC4CN5CCC4CC5)(C1)CC(c1ccccc1)(C3)C2 | [
"anti viral"
] |
The molecule is both a gsk3 inhibitor and a protein kinase inhibitor. | Nc1cnnc(Nc2ccc3cn[nH]c3c2)c1-c1n[nH]c2ccccc12 | [
"gsk3 inhibitor",
"protein kinase inhibitor"
] |
The molecule is a glucagon receptor antagonist. | CC(C)(C)CCC(c1ccc(C(=O)NCc2nn[nH]n2)cc1)N1C(=O)C(c2ccc(F)cc2)=NC12CCC(C(C)(C)C)CC2 | [
"glucagon receptor antagonist"
] |
The molecule is a oxytocin antagonist. | CON=C1CC(C(=O)NC(CO)C(O)c2ccc([N+](=O)[O-])cc2)N(C(=O)c2ccc(-c3ccccc3)cc2)C1 | [
"oxytocin antagonist"
] |
The molecule is a gcn2 inhibitor and is treatment of disorder. | C=NC=C(c1cccc(N2CCN(C(C)=O)CC2)n1)N1C=C(C(F)(F)F)N=CC1 | [
"gcn2 inhibitor",
"treatment of disorder"
] |
The molecule is a cholesterol translocation that impacts diabetic heart disease, non-alcoholic fatty liver disease, aging, and barth syndrome. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Diabetic heart disease",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Aging",
"Barth syndrome",
"Tangier disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase"
] |
The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts non-alcoholic fatty liver disease and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Diabetic heart disease",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Aging"
] |
The molecule is a nutrient that affects breast cancer by impacting atherosclerosis, cervical cancer, and ulcerative colitis. | CCCCC/C=C\C=C/[C@@H](O)C/C=C\C/C=C/CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCC | [
"Atherosclerosis",
"nutrient",
"Cervical cancer",
"Ulcerative colitis",
"Breast cancer"
] |
The molecule is a energy storage and a inflammatory that impacts cancer, atherosclerosis, obesity, and cardiovascular disease. The molecule is a thyroxine treatment and fat storage, and it impacts metabolic syndrome. The molecule is a nutrient, a membrane stabilizer, and a energy source, and it impacts pancreatitis. | CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)CC | [
"Energy storage",
"Cancer",
"Atherosclerosis",
"Obesity",
"inflammatory",
"Cardiovascular disease",
"Metabolic syndrome",
"Thyroxine treatment",
"Fat storage",
"Pancreatitis",
"nutrient",
"Membrane stabilizer",
"Energy source"
] |
The molecule is a diabetes treatment and is obesity treatment. | COc1cc(N2CCC(Oc3ccc(OC(F)(F)F)cc3)C2=O)ccc1OCCS(C)(=O)=O | [
"diabetes treatment",
"obesity treatment"
] |
The molecule is a cancer treatment. | C=CC=C1CCC2C(=C1CCC)C(c1ccc(N(CC)CC)cc1)CC1(C)C(O)CCC21 | [
"cancer treatment"
] |
The molecule is a apoptosis, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts tangier disease and diabetic heart disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and aging. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"Tangier disease",
"Apoptosis",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Aging"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts diabetic heart disease, aging, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, cholesterol translocation that impacts tangier disease and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C | [
"Apoptosis",
"Diabetic heart disease",
"Aging",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation"
] |
The molecule is a histone deacetylase inhibitor and is hiv treatment. | C=CCCC1=NC(CCc2ccc(F)cc2)CC=C1 | [
"hiv treatment",
"histone deacetylase inhibitor"
] |
The molecule is a membrane stabilizer, surfactant, food additive, apoptosis. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts aging, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a emulsifier and a energy source, it impacts tangier disease, and is smooth. The molecule is a nutritional supplement, energy storage, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome. | CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | [
"Membrane stabilizer",
"surfactant",
"food additive",
"Apoptosis",
"Aging",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Emulsifier",
"Smooth",
"Energy source",
"Tangier disease",
"Barth syndrome",
"Nutritional supplement",
"Energy storage",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase"
] |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts tangier disease, diabetic heart disease, and barth syndrome. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease and aging. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)CC | [
"Tangier disease",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Barth syndrome",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing cytochrome oxidase"
] |
The molecule is a energy storage, inflammatory, energy source that impacts thyroxine treatment, atherosclerosis, and cardiovascular disease. The molecule is a membrane stabilizer that impacts both pancreatitis and obesity. The molecule is a fat storage and a nutrient, impacting both metabolic syndrome and cancer. | CCC(C)CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC | [
"Energy storage",
"Thyroxine treatment",
"Atherosclerosis",
"inflammatory",
"Energy source",
"Cardiovascular disease",
"Pancreatitis",
"Membrane stabilizer",
"Obesity",
"Fat storage",
"nutrient",
"Metabolic syndrome",
"Cancer"
] |
The molecule is a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation, apoptosis that impacts aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Diabetic heart disease",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Aging",
"Cholesterol translocation",
"Apoptosis"
] |
The molecule is a protein kinase inhibitor, anti cancer, kinase inhibitor, angiogenesis inhibitor, anti inflammatory, and modulate. | Cc1c(C(F)(F)F)ccc(N(C)CCCN(C)C)c1N | [
"protein kinase inhibitor",
"anti cancer",
"kinase inhibitor",
"anti inflammatory",
"modulate",
"angiogenesis inhibitor"
] |
The molecule is a fat storage, inflammatory, membrane stabilizer that impacts thyroxine treatment, atherosclerosis, and obesity. The molecule is a nutrient and energy source, and it impacts metabolic syndrome. The molecule is a energy storage that affects cancer by impacting both pancreatitis and cardiovascular disease. | CCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)COC(=O)CCCCCCCCC(C)CC | [
"Thyroxine treatment",
"Fat storage",
"inflammatory",
"Atherosclerosis",
"Membrane stabilizer",
"Obesity",
"nutrient",
"Metabolic syndrome",
"Energy source",
"Pancreatitis",
"Cancer",
"Cardiovascular disease",
"Energy storage"
] |
The molecule is a nutrient, a flavoring agent, coconut, oily, and butter. | c1cnc(CC2CCCCC2)cn1 | [
"nutrient",
"coconut",
"Flavoring agent",
"oily",
"butter"
] |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts aging and barth syndrome. | CCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Aging",
"Barth syndrome",
"Stabilizing mitochondrial structure"
] |
The molecule is a energy source, inflammatory, nutrient that impacts pancreatitis, atherosclerosis, and metabolic syndrome. The molecule is a fat storage that affects cancer by impacting obesity. The molecule is a membrane stabilizer and a energy storage, impacting both cardiovascular disease and thyroxine treatment. | CCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C | [
"Pancreatitis",
"Energy source",
"inflammatory",
"nutrient",
"Atherosclerosis",
"Metabolic syndrome",
"Cancer",
"Obesity",
"Fat storage",
"Cardiovascular disease",
"Membrane stabilizer",
"Thyroxine treatment",
"Energy storage"
] |
The molecule is a protisticide and is both allelochemic and belongs to the carcinogenic and pesticide classes of molecules. | CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1.Cl | [
"carcinogenic",
"allelochemic",
"pesticide",
"protisticide"
] |
The molecule is a mdm2 inhibitor, bcl2 inhibitor, mek inhibitor, egfr inhibitor and belongs to the cancer treatment class of molecules. | Cn1c(Nc2ccc(Br)cc2F)nc2c(F)cc(C(=O)NOCCO)cc21 | [
"cancer treatment",
"mdm2 inhibitor",
"bcl2 inhibitor",
"mek inhibitor",
"egfr inhibitor"
] |
The molecule is spicy, herbal, and leafy. | O=P([O-])([O-])OP(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+].[Na+] | [
"spicy",
"herbal",
"leafy"
] |
The molecule is a kinase inhibitor. | CCNC(C)NCCC(C)(C)C | [
"kinase inhibitor"
] |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation. It impacts non-alcoholic fatty liver disease, aging, tangier disease, barth syndrome, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Aging",
"Tangier disease",
"Barth syndrome",
"Diabetic heart disease"
] |
The molecule is a nutrient. | CC/C=C\C[C@H](O)/C=C/C=C\C=C\[C@H](O)C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCC/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](N)C(=O)O | [
"nutrient"
] |
The molecule is a orexin receptor modulator. | Cc1cc(C)nc(N2CC3CNC(C(=O)c4occc4C)C3C2)n1 | [
"orexin receptor modulator"
] |
The molecule is a cholesterol translocation that impacts diabetic heart disease, aging, barth syndrome, and tangier disease. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC | [
"Diabetic heart disease",
"Aging",
"Cholesterol translocation",
"Barth syndrome",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase"
] |
The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts aging, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing mitochondrial structure that impacts barth syndrome and tangier disease. | CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)C | [
"Stabilizing cytochrome oxidase",
"Aging",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Tangier disease",
"Stabilizing mitochondrial structure"
] |
It influences both breast cancer and colorectal cancer, as well as affecting seizure and cardiovascular disease. It impacts stomach cancer, diabetes mellitus, parkinson's disease, and alzheimer's disease. | CC/C=C/C/C=C/C=C/C(O)CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CCCCCCC/C=C\C/C=C\CCC | [
"Breast cancer",
"Colorectal cancer",
"Seizure",
"Cardiovascular disease",
"Stomach cancer",
"Diabetes mellitus",
"Parkinson's disease",
"Alzheimer's Disease"
] |
It belongs to the anti tussive class of molecules. | C=CCN1CCC23c4c5ccc(O)c4OC2C(OS(=O)(=O)C=Cc2ccoc2)CCC3(O)C1C5 | [
"anti tussive"
] |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts barth syndrome and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Cholesterol translocation",
"Diabetic heart disease",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Aging",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts barth syndrome, diabetic heart disease, and tangier disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts non-alcoholic fatty liver disease and aging. | CCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC | [
"Barth syndrome",
"Diabetic heart disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Aging",
"Stabilizing mitochondrial structure",
"Cholesterol translocation"
] |
The molecule is a fat storage that impacts both pancreatitis and atherosclerosis. The molecule is a nutrient that impacts thyroxine treatment, metabolic syndrome, and cardiovascular disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Pancreatitis",
"Fat storage",
"Atherosclerosis",
"Thyroxine treatment",
"Metabolic syndrome",
"nutrient",
"Cardiovascular disease"
] |
The molecule is a anti hiv and belongs to the anti inflammatory class of molecules. | CCCCC1(O)C(=O)NN(c2ccccc2-c2ccc(O)cc2)C1=O | [
"anti inflammatory",
"anti hiv"
] |
The molecule is a nutrient that impacts both thyroxine treatment and metabolic syndrome. The molecule is a fat storage that impacts atherosclerosis, pancreatitis, and cardiovascular disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC | [
"Thyroxine treatment",
"Metabolic syndrome",
"nutrient",
"Fat storage",
"Atherosclerosis",
"Pancreatitis",
"Cardiovascular disease"
] |
It belongs to the light-emitting class of molecules. | c1ccc(-c2nc(-c3ccc(-c4cccnc4)cc3)cc(-c3cccc(-c4ccc(-c5cccc6c5-c5ccccc5C65CCCCC5)cc4)c3)n2)cc1 | [
"light-emitting"
] |
The molecule is a inflammatory and a fat storage that impacts pancreatitis, cardiovascular disease, obesity, and atherosclerosis. The molecule is a energy source and belongs to the thyroxine treatment class of molecules, impacting metabolic syndrome. The molecule is a nutrient, energy storage, membrane stabilizer with an effect on cancer. | CCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | [
"Pancreatitis",
"Cardiovascular disease",
"Obesity",
"Atherosclerosis",
"inflammatory",
"Fat storage",
"Energy source",
"Thyroxine treatment",
"Metabolic syndrome",
"nutrient",
"Cancer",
"Energy storage",
"Membrane stabilizer"
] |
The molecule is a energy source, food additive, surfactant, and nutrient, impacts alzheimer's disease, and is smooth. The molecule is a energy storage that impacts both parkinson's disease and diabetes mellitus type 2. The molecule is a membrane stabilizer, a nutritional supplement, and a emulsifier, and it impacts non-alcoholic fatty liver disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OCCN | [
"Energy source",
"Alzheimer's Disease",
"food additive",
"surfactant",
"nutrient",
"Smooth",
"Parkinson's disease",
"Energy storage",
"Diabetes mellitus type 2",
"Membrane stabilizer",
"Nutritional supplement",
"Non-alcoholic fatty liver disease",
"Emulsifier"
] |
The molecule is a nutrient that impacts parkinson's disease, diabetes mellitus type 2, alzheimer's disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)CC(=O)[C@@H]1/C=C/[C@@H](O)CCCCC | [
"Parkinson's disease",
"Diabetes mellitus type 2",
"Alzheimer's Disease",
"nutrient",
"Non-alcoholic fatty liver disease"
] |
The molecule is a anti tumoral and a anti tumour, as well as anti tumor agent and anti tumor. | Cc1ccc(S(=O)(=O)Nc2ncc(OC3CCCCO3)c3cc4cccnc4n23)cc1 | [
"anti tumor agent",
"anti tumoral",
"anti tumor",
"anti tumour"
] |
It impacts diabetes mellitus type 1, pick's disease, and cardiovascular disease. The molecule is a nutrient that impacts atherosclerosis, diabetes mellitus type 2, and insulin resistance. | Cc1cccc(OS(=O)(=O)O)c1O | [
"Diabetes mellitus type 1",
"Pick's disease",
"Cardiovascular disease",
"Atherosclerosis",
"Diabetes mellitus type 2",
"nutrient",
"Insulin resistance"
] |
The molecule is a fat storage and nutrient, and it impacts metabolic syndrome. It impacts thyroxine treatment, cardiovascular disease, atherosclerosis, and pancreatitis. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COC(=O)CCCCCCCCCCCCCCCCCCC | [
"Metabolic syndrome",
"Fat storage",
"nutrient",
"Thyroxine treatment",
"Cardiovascular disease",
"Atherosclerosis",
"Pancreatitis"
] |
The molecule is a cholesterol translocation that impacts non-alcoholic fatty liver disease, tangier disease, aging, and barth syndrome. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC | [
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Cholesterol translocation",
"Aging",
"Barth syndrome",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a fat storage, membrane stabilizer, inflammatory, energy storage that impacts obesity and metabolic syndrome. It has an effect on cancer, impacting both pancreatitis and cardiovascular disease. The molecule is a energy source and a nutrient, impacting both thyroxine treatment and atherosclerosis. | CCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)C | [
"Fat storage",
"Membrane stabilizer",
"Obesity",
"inflammatory",
"Metabolic syndrome",
"Energy storage",
"Pancreatitis",
"Cardiovascular disease",
"Cancer",
"Thyroxine treatment",
"Energy source",
"nutrient",
"Atherosclerosis"
] |
The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Barth syndrome",
"Apoptosis",
"Cholesterol translocation",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, breast cancer, and ulcerative colitis. | CCCCC/C=C\C=C/[C@H](O)C/C=C\C/C=C/CCCC(=O)O[C@H](COC(C)=O)COP(=O)([O-])OCC[N+](C)(C)C | [
"nutrient",
"Atherosclerosis",
"Breast cancer",
"Ulcerative colitis",
"Cervical cancer"
] |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and aging. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts tangier disease, diabetic heart disease, and barth syndrome. | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Aging",
"Tangier disease",
"Diabetic heart disease",
"Barth syndrome",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a cholesterol translocation, a emulsifier, and a surfactant, and it impacts aging. The molecule is a stabilizing cytochrome oxidase, food additive, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a energy storage, it impacts barth syndrome, and is smooth. The molecule is a apoptosis, nutritional supplement, energy source, membrane stabilizer that impacts tangier disease. | CCC(C)CCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C | [
"Cholesterol translocation",
"Emulsifier",
"surfactant",
"Aging",
"Stabilizing cytochrome oxidase",
"food additive",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Smooth",
"Energy storage",
"Apoptosis",
"Tangier disease",
"Nutritional supplement",
"Energy source",
"Membrane stabilizer"
] |
The molecule is a nutrient and fat storage, and it impacts pancreatitis. The molecule is a member of the thyroxine treatment class and affects atherosclerosis, metabolic syndrome, and cardiovascular disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=C\CCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\CCCCC | [
"nutrient",
"Pancreatitis",
"Fat storage",
"Atherosclerosis",
"Thyroxine treatment",
"Metabolic syndrome",
"Cardiovascular disease"
] |
The molecule is a thyroxine treatment and membrane stabilizer, affecting cancer, and impacting pancreatitis, atherosclerosis, and obesity. The molecule is a energy source and nutrient, and it impacts metabolic syndrome. The molecule is a energy storage, a inflammatory, and a fat storage, and it impacts cardiovascular disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C | [
"Pancreatitis",
"Thyroxine treatment",
"Atherosclerosis",
"Membrane stabilizer",
"Obesity",
"Cancer",
"Energy source",
"nutrient",
"Metabolic syndrome",
"Cardiovascular disease",
"Energy storage",
"inflammatory",
"Fat storage"
] |
The molecule is vegetable, sulfur, smoky, and savory. The molecule is a nutrient and a flavoring agent, as well as sulfurous and alliaceous. | CC1=C(CCC(C)O)C(C)(C)CCC1 | [
"vegetable",
"sulfur",
"smoky",
"savory",
"nutrient",
"sulfurous",
"alliaceous",
"Flavoring agent"
] |
The molecule is a surfactant, nutrient, emulsifier, energy source, energy storage, membrane stabilizer. | C/C=C\c1ccc(OCC=C(C)C)cc1 | [
"surfactant",
"nutrient",
"Emulsifier",
"Energy source",
"Energy storage",
"Membrane stabilizer"
] |
It belongs to the inflammatory treatment class of molecules. | COc1ccc(N(C)S(=O)(=O)c2ccc(C)cc2)cc1CNC1CCCNC1c1ccccc1.Cl.Cl | [
"inflammatory treatment"
] |
The molecule is both a fluorescent dye and a fluorescent. | CC1=NN(CCCS(=O)(=O)O)C(=CC=CC2=[N+](CCCCCOC=O)c3ccccc3C2(C)CCCS(=O)(=O)O)C1(C)CCCS(=O)(=O)O | [
"fluorescent dye",
"fluorescent"
] |
It has an effect on colorectal cancer, and impacts stomach cancer, diabetes mellitus, and parkinson's disease. It has an effect on breast cancer, and impacts cardiovascular disease, alzheimer's disease, and seizure. | CCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCC(O)C(O)C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O | [
"Stomach cancer",
"Diabetes mellitus",
"Colorectal cancer",
"Parkinson's disease",
"Cardiovascular disease",
"Breast cancer",
"Alzheimer's Disease",
"Seizure"
] |
The molecule is a kinase inhibitor. | COCc1nc2nccc(-c3ccc(OCC(C)(N)CC(C)C)c(C)c3)c2[nH]1 | [
"kinase inhibitor"
] |
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, breast cancer, and ulcerative colitis. | CC/C=C\C/C=C\C/C=C\C/C=C\C=C/C(O)C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCC/C=C\C/C=C\C/C=C\CCCCCC)COP(=O)([O-])OCC[N+](C)(C)C | [
"Atherosclerosis",
"Breast cancer",
"Cervical cancer",
"Ulcerative colitis",
"nutrient"
] |
The molecule is a food additive, a emulsifier, and a energy source that impacts both alzheimer's disease and parkinson's disease, and is smooth. The molecule is a energy storage, a surfactant, and a membrane stabilizer. The molecule is a nutritional supplement and a nutrient, impacting both diabetes mellitus type 2 and non-alcoholic fatty liver disease. | CCCCCc1cc(C)c(CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCc2oc(CCCCC)cc2C)o1 | [
"Smooth",
"food additive",
"Alzheimer's Disease",
"Emulsifier",
"Energy source",
"Parkinson's disease",
"Energy storage",
"surfactant",
"Membrane stabilizer",
"Nutritional supplement",
"Diabetes mellitus type 2",
"nutrient",
"Non-alcoholic fatty liver disease"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, non-alcoholic fatty liver disease, and tangier disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts barth syndrome and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Cholesterol translocation",
"Apoptosis",
"Aging"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts aging and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Aging",
"Barth syndrome",
"Stabilizing mitochondrial structure"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts tangier disease and aging. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, and diabetic heart disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Aging",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Diabetic heart disease"
] |
The molecule is a nutrient and fat storage, and it impacts cardiovascular disease. The molecule is a thyroxine treatment that impacts pancreatitis, atherosclerosis, and metabolic syndrome. | CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OCCCCCCCCCCCCCCCCCC | [
"nutrient",
"Fat storage",
"Cardiovascular disease",
"Pancreatitis",
"Atherosclerosis",
"Thyroxine treatment",
"Metabolic syndrome"
] |
It belongs to the tumor treatment class of molecules. | CCN1CC(C(C)Cl)c2c1cc(O)c1cccc(C)c21 | [
"tumor treatment"
] |
It impacts nausea, multi-infarct dementia, confusion, and bleeding. The molecule is a biomarker and a cross-linking reagent that impacts weight loss, cardiovascular disease, and agitation. It impacts coma. When heated to decomposition it emits toxic fumes of nitrogen oxides. It impacts both vomiting and kidney disease. It impacts uremia, psychosis, chronic kidney disease, seizure, and kidney transplantation. | CN1CCc2cc3c(cc2C(=O)Cc2ccc4c(c2C1)OCO4)OCO3 | [
"Nausea",
"Multi-infarct dementia",
"Confusion",
"Bleeding",
"biomarker",
"Weight loss",
"Cardiovascular disease",
"Agitation",
"cross-linking reagent",
"Coma",
"Decomposition_evaluation",
"Vomiting",
"Kidney disease",
"Uremia",
"Psychosis",
"Chronic kidney disease",
"Seizure",
"Kidney transplantation"
] |
The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts aging, diabetic heart disease, and barth syndrome. The molecule is a apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Aging",
"Diabetic heart disease",
"Barth syndrome",
"Tangier disease",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation"
] |
It belongs to the histamine receptor antagonist class of molecules. | OC(c1nc2ccccc2n1Cc1ccccc1)C1CCN(Cc2ccccc2)C(Cc2ccccc2)C1 | [
"histamine receptor antagonist"
] |
The molecule is a nutrient that affects cervical cancer by impacting breast cancer, ulcerative colitis, and atherosclerosis. | CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\CC1OC1CCCCC)COP(=O)([O-])OCC[N+](C)(C)C | [
"Breast cancer",
"Cervical cancer",
"Ulcerative colitis",
"Atherosclerosis",
"nutrient"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation, stabilizing mitochondrial structure that impacts aging. The molecule is a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Aging",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Diabetic heart disease",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a stabilizing cytochrome oxidase and smooth, impacting both barth syndrome and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, energy source, stabilizing mitochondrial structure, food additive, emulsifier. The molecule is a cholesterol translocation, a energy storage, and a nutritional supplement, and it impacts tangier disease. The molecule is a surfactant, membrane stabilizer, apoptosis that impacts non-alcoholic fatty liver disease and aging. | CCC(C)CCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC | [
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Diabetic heart disease",
"Smooth",
"Proton trap for oxidative phosphorylation",
"Energy source",
"Stabilizing mitochondrial structure",
"food additive",
"Emulsifier",
"Tangier disease",
"Cholesterol translocation",
"Energy storage",
"Nutritional supplement",
"Non-alcoholic fatty liver disease",
"Aging",
"surfactant",
"Membrane stabilizer",
"Apoptosis"
] |
The molecule is a nutrient, energy source, inflammatory, membrane stabilizer that has an effect on cancer and impacts obesity. The molecule is a fat storage that impacts both atherosclerosis and pancreatitis. The molecule is a thyroxine treatment and a energy storage, impacting both metabolic syndrome and cardiovascular disease. | CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC(C)CC | [
"Cancer",
"nutrient",
"Energy source",
"Obesity",
"inflammatory",
"Membrane stabilizer",
"Fat storage",
"Atherosclerosis",
"Pancreatitis",
"Thyroxine treatment",
"Metabolic syndrome",
"Energy storage",
"Cardiovascular disease"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts barth syndrome and aging. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Cholesterol translocation",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Aging",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing cytochrome oxidase"
] |
The molecule is a fat storage and a energy storage that impacts obesity, metabolic syndrome, atherosclerosis, and cancer. The molecule is a energy source and membrane stabilizer, and it impacts cardiovascular disease. The molecule is a inflammatory and a nutrient, impacting both thyroxine treatment and pancreatitis. | CCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Obesity",
"Metabolic syndrome",
"Fat storage",
"Atherosclerosis",
"Cancer",
"Energy storage",
"Energy source",
"Cardiovascular disease",
"Membrane stabilizer",
"Thyroxine treatment",
"inflammatory",
"nutrient",
"Pancreatitis"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation that impacts diabetic heart disease and aging. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Aging",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Barth syndrome"
] |
The molecule is a gaba antagonist, which is both a member of the agrochemical and central nervous system stimulant classes, is fruity, and has a Odorless as well as a Sweet taste. The molecule is a gaba-gated chloride channel antagonist that is sweet and vegetable. The molecule is green. It belongs to the neurotoxin class of molecules. When heated to decomposition it emits acrid smoke and irritating fumes. | OCCO | [
"Odor_evaluation",
"GABA antagonist",
"agrochemical",
"fruity",
"taste_evaluation",
"central nervous system stimulant",
"sweet",
"GABA-gated chloride channel antagonist",
"vegetable",
"green",
"neurotoxin",
"Decomposition_evaluation"
] |
The molecule is a organic light-emitting device. | CCC(c1ccccc1-c1ccccc1C)c1cccc2c1oc1c(C#N)ccc(-c3ccc4sc5ccccc5c4c3)c12 | [
"organic light-emitting device"
] |
The molecule is a egfr inhibitor, a kras inhibitor, and a tyrosine kinase inhibitor. | Cc1cccc(-n2ncc(C)cc2=O)c1 | [
"egfr inhibitor",
"kras inhibitor",
"tyrosine kinase inhibitor"
] |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts tangier disease, diabetic heart disease, and aging. | CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Diabetic heart disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Apoptosis"
] |
The molecule is a fat storage, inflammatory, and energy source that has an effect on cancer and impacts both pancreatitis and atherosclerosis. The molecule is a membrane stabilizer that impacts both metabolic syndrome and obesity. The molecule is a energy storage and nutrient, belonging to the thyroxine treatment class of molecules, and impacts cardiovascular disease. | CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC)COC(=O)CCCCCCCCC(C)C | [
"Fat storage",
"Pancreatitis",
"inflammatory",
"Energy source",
"Cancer",
"Atherosclerosis",
"Membrane stabilizer",
"Metabolic syndrome",
"Obesity",
"Thyroxine treatment",
"Cardiovascular disease",
"Energy storage",
"nutrient"
] |
The molecule is a glycogen phosphorylase inhibitor and belongs to the anti diabetic class of molecules. | COCCN(C(=O)c1cc(NC(=O)c2cc(F)c(F)cc2Cl)n[nH]1)C1CCCC1 | [
"glycogen phosphorylase inhibitor",
"anti diabetic"
] |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts tangier disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCC(C)CC | [
"Cholesterol translocation",
"Tangier disease",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Aging"
] |
The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts aging and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, barth syndrome, and tangier disease. | CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Aging",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Tangier disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure"
] |
The molecule is a surfactant, energy source, food additive, stabilizing cytochrome oxidase. The molecule is a apoptosis and a nutritional supplement that impacts barth syndrome, aging, and tangier disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation, impacting both diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a membrane stabilizer, emulsifier, energy storage, stabilizing mitochondrial structure, and smooth. | CCCCCC/C=C\C=C/CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"surfactant",
"Energy source",
"food additive",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Aging",
"Tangier disease",
"Apoptosis",
"Nutritional supplement",
"Diabetic heart disease",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Membrane stabilizer",
"Emulsifier",
"Smooth",
"Energy storage",
"Stabilizing mitochondrial structure"
] |